What are the limitations of the itp bleeding score?

While the itp bleeding score is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the itp bleeding score to ensure safe bedside use and optimal diagnostic accuracy.

How does the itp bleeding score compare to other hematology scores?

The itp bleeding score is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the itp bleeding score free to use?

Yes. OpiCalc provides the itp bleeding score completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

OpiCalc

927 Clinical Tools

OpiCalc

4Ts Score (HIT)aaIPI (Age-adjusted IPI)ABC Score (Massive Transfusion)Absolute Neutrophil Count Age-adjusted D-dimer Threshold aGvHD Grading (Glucksberg/MAGIC)AL Amyloidosis Staging (Mayo)Anti-Xa Monitoring Interpreter Antiphospholipid Syndrome Classification Binet / Rai Staging (CML)Blood Volume Calculator Caprini VTE Risk CISNE Score CLL-IPI Coombs-Negative Haemolysis Checklist Corrected Reticulocyte Count CRS Grading (ASTCT 2019)DAT Interpretation Algorithm Deauville Score Interpreter DIC Score (ISTH)DIPSS (MF)DIPSS-Plus (MF)DOAC Dose Selector DOAC Renal Dose Adjustment DRI (Disease Risk Index)Durie-Salmon Staging (historical)EBMT Risk Score ELN 2022 AML Risk Classification ELTS Score (CML)England & Fraser Index EUTOS Score (CML)Expected Hb Rise per RBC Unit Factor Inhibitor Bethesda Titre Interpreter Febrile Neutropaenia Risk (MASCC)Fibrinogen Replacement FLIPI (Follicular Lymphoma IPI)FLIPI-2 French TTP Score GAPSS (Global APS Score)Haemophilia Severity Classification HbS Percentage Target Calculator HCT-CI (Comorbidity Index)HEP Score Heparin Nomogram (Weight-based)Hepatic Iron Index HERDOO2 Rule HFE Haemochromatosis Risk Estimator ICANS Grading (ASTCT 2019)IMWG Response Criteria (Myeloma)IPI (International Prognostic Index)IPSID / Lugano Classification IPSS-M (Molecular IPSS)IPSS-R (Revised IPSS for MDS)Iron Deficit Calculator (Ganzoni Formula)ISS (Myeloma)ISTH Bleeding Assessment Tool (BAT)ISTH Non-Overt DIC Score ITP Bleeding Score iwCLL Response Criteria (2018)IWG ITP Response Criteria JAK2V617F Allele Burden Interpreter Karnofsky Performance Scale Leucostasis Risk Threshold Lupus Anticoagulant (LAC) Reporting Framework MAGIC aGvHD Biomarker Score MCV-based Anaemia Algorithm Mentzer Index MIPI (MCL IPI)MIPSS70+ v2.0 (MF)Mixing Study Interpretation MRD Assessment Threshold Interpreter mSMART 3.0 (Myeloma)MTP Activation Criteria NCCN-IPI NIH Chronic GvHD Scoring NTDT Iron Burden Estimator Padua RAM PBT (Paediatric BAT)PCNSL MSKCC Score PERC Rule Perioperative Anticoagulation Bridging PESI Score (PE Mortality)PLASMIC Score Platelet Increment Calculator (CCI)PNH Clone Size Interpreter R-IPI (Revised IPI)R-ISS (Revised ISS)Reticulocyte Index (RPI)Revised Geneva Score (PE)Revised Response Criteria (NHL)Revised Zubrod / ECOG Performance Shine & Lal Index Sickle Cell Disease Risk (TCD)SLiM-CRAB Criteria SOKAL Score (CML)Sokal/EUTOS/ELTS Comparison sPESI (Simplified PESI)TACO Risk Score Thalassaemia Transfusion Threshold Thrombocytopaenia Differential Thrombophilia Screening Eligibility Algorithm Time in Therapeutic Range (TTR)TLS Risk Classification Transferrin Saturation Calculator Vienna Prediction Model von Willebrand Factor Activity Interpreter Warfarin Dose Calculator Wells Score (DVT)Wells Score (PE)WHO 2022 AML Classification Mapper WHO Bleeding Scale YEARS Algorithm

ITP Bleeding Score

ITP-BAT SMO Score: Quantifying bleeding in ITP. Mucosal (M) and Organ (O) bleeding are higher priority than Skin (S) manifestations.

Skin (S) score

Mucosa (M) score

Organ (O) score

Includes GI, CNS, Pulmonary, GU

Composite Bleeding Profile

S0 M0 O0

Dry Purpura / Low Risk

Bleeding risk is clinically low. Management depends on baseline platelet count and trend.

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Standardized scoring of bleeding severity in patients with Immune Thrombocytopenia (ITP).

To guide treatment initiation (targeting the "Bleeding" rather than just the "Number").

Symmetry of reporting for clinical trials in ITP.

Patient Population

Adult and pediatric patients with diagnosed ITP and low platelet counts.

Section 2

Formula & Logic

Organ Domains (0–4)

Domain	Grade 0	Grade 4 (Severe)
Skin (S)	None	Large hematomas, extensive bruising
Mucosa (M)	None	Active bleeding requiring intervention (e.g. packing)
Organs (O)	None	CNS, Pulmonary, or Massive GI hemorrhage

Interpretation

The SMO score (e.g., S2, M1, O0) provides a rapid phenotype. A score of ≥ 2 in Mucosa or ≥ 1 in Organs typically warrants immediate systemic therapy (IVIG/Steroids) regardless of the platelet count.

Section 3

Pearls/Pitfalls

Treat the Patient, Not the Number

Many patients with platelets < 10k are asymptomatic (S0, M0, O0) and may be managed expectantly in certain settings. Conversely, a patient with platelets of 25k and active mucosal bleeding (M3) requires urgent rescue therapy.

Section 4

Evidence Appraisal

Primary Consensus

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.

Rodeghiero F et al. • Blood. 2013;121(14):2596-606.

View Source

Section 5

Literature

Evolution

Developed to replace ad-hoc descriptions of bleeding ("wet" vs. "dry" purpura) with a rigorous, evidence-based scale similar to those used in Haemophilia.

Last Comprehensive Review: 2026

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Standardized scoring of bleeding severity in patients with Immune Thrombocytopenia (ITP).

To guide treatment initiation (targeting the "Bleeding" rather than just the "Number").

Symmetry of reporting for clinical trials in ITP.

Patient Population

Adult and pediatric patients with diagnosed ITP and low platelet counts.

Section 2

Formula & Logic

Organ Domains (0–4)

Domain	Grade 0	Grade 4 (Severe)
Skin (S)	None	Large hematomas, extensive bruising
Mucosa (M)	None	Active bleeding requiring intervention (e.g. packing)
Organs (O)	None	CNS, Pulmonary, or Massive GI hemorrhage

Interpretation

Section 3

Pearls/Pitfalls

Treat the Patient, Not the Number

Section 4

Evidence Appraisal

Primary Consensus

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.

Rodeghiero F et al. • Blood. 2013;121(14):2596-606.

View Source

Section 5

Literature

Evolution

Developed to replace ad-hoc descriptions of bleeding ("wet" vs. "dry" purpura) with a rigorous, evidence-based scale similar to those used in Haemophilia.

Last Comprehensive Review: 2026

Related Hematology Tools

DRI

MAGIC aGvHD Biomarker Score

CRS Grading

ICANS Grading

aGvHD Grading

NIH Chronic GvHD Scoring

Sickle Cell Disease Risk

Thalassaemia Transfusion Threshold

NTDT Iron Burden Estimator

HbS Percentage Target Calculator

Have feedback about this calculator?Let us know.

ITP Bleeding Score

ITP-BAT SMO Score: Quantifying bleeding in ITP. Mucosal (M) and Organ (O) bleeding are higher priority than Skin (S) manifestations.

Skin (S) score

Mucosa (M) score

Organ (O) score

Includes GI, CNS, Pulmonary, GU

Composite Bleeding Profile

S0 M0 O0

Dry Purpura / Low Risk

Bleeding risk is clinically low. Management depends on baseline platelet count and trend.

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Standardized scoring of bleeding severity in patients with Immune Thrombocytopenia (ITP).

To guide treatment initiation (targeting the "Bleeding" rather than just the "Number").

Symmetry of reporting for clinical trials in ITP.

Patient Population

Adult and pediatric patients with diagnosed ITP and low platelet counts.

Section 2

Formula & Logic

Organ Domains (0–4)

Domain	Grade 0	Grade 4 (Severe)
Skin (S)	None	Large hematomas, extensive bruising
Mucosa (M)	None	Active bleeding requiring intervention (e.g. packing)
Organs (O)	None	CNS, Pulmonary, or Massive GI hemorrhage

Interpretation

Section 3

Pearls/Pitfalls

Treat the Patient, Not the Number

Section 4

Evidence Appraisal

Primary Consensus

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.

Rodeghiero F et al. • Blood. 2013;121(14):2596-606.

View Source

Section 5

Literature

Evolution

Developed to replace ad-hoc descriptions of bleeding ("wet" vs. "dry" purpura) with a rigorous, evidence-based scale similar to those used in Haemophilia.

Last Comprehensive Review: 2026

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Standardized scoring of bleeding severity in patients with Immune Thrombocytopenia (ITP).

To guide treatment initiation (targeting the "Bleeding" rather than just the "Number").

Symmetry of reporting for clinical trials in ITP.

Patient Population

Adult and pediatric patients with diagnosed ITP and low platelet counts.

Section 2

Formula & Logic

Organ Domains (0–4)

Domain	Grade 0	Grade 4 (Severe)
Skin (S)	None	Large hematomas, extensive bruising
Mucosa (M)	None	Active bleeding requiring intervention (e.g. packing)
Organs (O)	None	CNS, Pulmonary, or Massive GI hemorrhage

Interpretation

Section 3

Pearls/Pitfalls

Treat the Patient, Not the Number

Section 4

Evidence Appraisal

Primary Consensus

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.

Rodeghiero F et al. • Blood. 2013;121(14):2596-606.

View Source

Section 5

Literature

Evolution

Developed to replace ad-hoc descriptions of bleeding ("wet" vs. "dry" purpura) with a rigorous, evidence-based scale similar to those used in Haemophilia.

Last Comprehensive Review: 2026

Related Hematology Tools

DRI

MAGIC aGvHD Biomarker Score

CRS Grading

ICANS Grading

aGvHD Grading

NIH Chronic GvHD Scoring

Sickle Cell Disease Risk

Thalassaemia Transfusion Threshold

NTDT Iron Burden Estimator

HbS Percentage Target Calculator

Have feedback about this calculator?Let us know.